| Entry |
|
|---|
| Name |
Insulin glargine (genetical recombination) (JAN);
Insulin glargine (USAN/INN);
Lantus (TN)
|
|---|
| Product |
|
|---|
| Formula |
C267H404N72O78S6
|
|---|
| Exact mass |
6058.8184
|
|---|
| Mol weight |
6062.8903
|
|---|
| Sequence |
(A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
Gln Leu Glu Asn Tyr Cys Gly (Disulfide bridge: 6-11)
(B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr
Arg Arg (Disulfide bridge: A7-B7; A20-B19) |
|---|
| Type |
Peptide |
|---|
| Activity |
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
CYP induction: CYP1A2 [HSA: 1544]
 |
|---|
| Structure map |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2492 Pancreatic hormones
D03250 Insulin glargine (genetical recombination) (JAN); Insulin glargine (USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10A INSULINS AND ANALOGUES
A10AE Insulins and analogues for injection, long-acting
A10AE04 Insulin glargine
D03250 Insulin glargine (genetical recombination) (JAN); Insulin glargine (USAN/INN)
USP drug classification [BR:br08302]
Blood Glucose Regulators
Insulins
Insulin, Long-acting
Insulin glargine
D03250 Insulin glargine (genetical recombination) (JAN); Insulin glargine (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokine receptors
Receptor tyrosine kinase
RTK class II (Insulin receptor family)
insulin receptor [HSA:3643] [KO:K04527]
Insulin glargine [ATC:A10AE04]
D03250 Insulin glargine (genetical recombination) (JAN); Insulin glargine (USAN/INN)
 |
|---|
| Other DBs |
CAS: 160337-95-1 PubChem: DrugBank: NIKKAJI: |
|---|
